Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DORB45
|
|||
| Drug Name |
Enfortumab
|
|||
| Synonyms |
ASG-2ME
Click to Show/Hide
|
|||
| Drug Type |
Antibody drug conjugate
|
|||
| Indication | Urothelial carcinoma [ICD-11: 2C92.0] | Approved | [1] | |
| Company |
Astellas Northbrook, IL Seattle Genetics Bothell, WA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nectin cell adhesion molecule 4 (NECTIN4) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Adherens junction | |||
| Reactome | Adherens junctions interactions | |||
| WikiPathways | Cell junction organization | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.